ANGELA LUNCZYNSKI: Open Payments
NPI 1184293177 · CHESTERTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 11 payments from 8 companies in 2025. Trend: 2023 $331 · 2024 $240 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $164 |
| Novo Nordisk Inc | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Dexcom, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: FARXIGA, AIRSUPRA, JARDIANCE, VRAYLAR, AREXVY, Dexcom G6 Transmitter, Wegovy, KRYSTEXXA.
Industry payments across MD — which companies pay providers there.
